Trial Profile
Adalimumab in patients with moderate-to-severe plaque psoriasis: REVEAL trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2013
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms REVEAL
- 12 Mar 2011 New trial record